estraderm mx 100 estradiol 100 microgram/24 hours transdermal drug delivery system sachet
juno pharmaceuticals pty ltd - estradiol hemihydrate, quantity: 3.09 mg (equivalent: estradiol, qty 3 mg) - drug delivery system, transdermal - excipient ingredients: isopropyl palmitate; polyethylene terephthalate; ethyl acetate; acrylic acid; 2-ethylhexyl acrylate; methyl acrylate; glycidyl methacrylate; 2,2'-azobisisobutyronitrile; hexane - menopausal symptoms: short-term treatment of signs and symptoms of oestrogen deficiency due to menopause, whether natural or surgically induced. in women with an intact uterus, oestrogen should always be opposed by progestogen in an adequate dosage regimen to ensure secretory transformation of the endometrium at regular intervals (refer to section 5.1 pharmacodynamic properties - clinical trials and section 4.2 dose and method of administration). prevention of post-menopausal bone mineral density loss: estraderm mx 50, 75 and 100 may be used for prevention of post-menopausal bone mineral density loss in women with an increased risk of future osteoporotic fractures who are intolerant of, or contraindicated for, other medicinal products approved for the prevention of bone mineral density loss. when prescribed solely for the prevention of postmenopausal bone mineral density loss, therapy should only be prescribed for women who are at high risk of future fracture and who are intolerant of, or contraindicated for, non-oestrogen products approved for prevention of bone mineral density loss. lifestyle modifications and the risk-benefit profile of estraderm mx should be taken into careful consideration and discussed with the patient to allow the patient to make an informed decision prior to prescribing( see section 4.4 special warnings and precautions for use and section 4.2 dose and method of administration). combination hrt should not be used in hysterectomised women because it is not needed in these women and it may increase risk of breast cancer.
inomax
linde healthcare ab - oxid dusnatý - hypertension, pulmonary; respiratory insufficiency - ostatné produkty dýchacej sústavy - inomax, v spojení s ventilačnej podpory a iných vhodných účinných látok, je uvedené:na liečbu novorodencov dojčiat ≥34 týždňov gravidity s hypoxic respiračné zlyhanie spojené s klinickými alebo echocardiographic dôkazy, pľúcnej hypertenzie, s cieľom zlepšiť okysličenie a znížiť potrebu extracorporeal membrány okysličenie;ako súčasť liečby z peri - a pooperačnej pľúcnej hypertenzie u dospelých a novorodencov novorodencov, dojčiat a batoliat, detí a dospievajúcich vo veku 0-17 rokov v spojení na operáciu srdca, v záujme selektívne zníženie pľúcny arteriálny tlak a zlepšiť právo komorovej funkcie a okysličenie.
φαρμακευτικο οξυγονο υγρο/linde med.gas.cr 100% v/v
ΛΙΝΤΕ ΕΛΛΑΣ ΜΟΝΟΠΡΟΣΩΠΗ ΕΤΑΙΡΕΙΑ ΠΕΡΙΟΡΙΣΜΕΝΗΣ ΕΥΘΥΝΗΣ Θέση Τρύπιο Λιθάρι, 196 00 Αττική 211.1045500 - oxygen - med.gas.cr (ΙΑΤΡΙΚΟ ΑΕΡΙΟ, ΚΡΥΟΓΟΝΟ) - 100% v/v - oxygen 100% - oxygen
medicinski kisik gtg plin 100 % medicinski plin, stisnjeni
kisik - medicinski plin, stisnjeni - kisik 100 % / 1 jeklenka - kisik
medicinski kisik gtg plin 100 % medicinski plin, stisnjeni
kisik - medicinski plin, stisnjeni - kisik 100 % / 1 jeklenka - kisik
acea 0.75% gel
ferndale pharmaceuticals ltd - metronidazole - cutaneous gel - 7.5mg/1gram
elelyso
pfizer new zealand limited - taliglucerase alfa 200 u (200 u deliverable, plus 6% overage) - powder for injection - 200 u - active: taliglucerase alfa 200 u (200 u deliverable, plus 6% overage) excipient: citric acid mannitol polysorbate 80 sodium citrate dihydrate - elelyso is indicated for long-term enzyme replacement therapy for adult and paediatric patients with a confirmed diagnosis of type 1 gaucher disease associated with at least one of the following: splenomegaly, hepatomegaly, anaemia, thrombocytopenia.
yin onn pearl ginseng cordyceps plus bai feng wan
herbal land manufacturing sdn bhd - citrus aurantium; poria cocos; sonchus asper; colla corii asini; trigonella frenum-graecum semen; scutellaria baicalensis radix; rhizoma notopterygium franchetii; cyperus rotundus; rhizoma atractylodis macrocephalae; rehmannia glutinosa rhizoma; radix paeonia lactiflora; radix codonopsis pilosulae; pearl powder; fructus amomum villosum; folium artemisia argyi; cuscuta chinensis semen; cordyceps sinensis sacc.; astragalus hoangtghy; angelica polymorpha radix; radix glycyrrhiza uralensis; radix panax ginsen -
silwet gold flydende middel
upl europe ltd. (tidligere: united phosphorus ltd.) - sprede-klæbemiddel - flydende middel - 1000 g/l sprede-klæbemiddel
profender
vetoquinol s.a. - emodepside, praziquantel - antiparasitiske produkter, insekticider og repellenter - dogs; cats - catsfor katte, der lider af, eller er i risiko fra, blandet parasitære infektioner forårsaget af rundorm og bændelorm af følgende arter:rundorme (nematoder)toxocara cati (mature adult, umodne voksne, l4 og l3);toxocara cati (l3 larver) – behandling af dronninger i slutningen af graviditeten for at forebygge lactogenic transmission til afkom;toxascaris leonina (mature adult, umodne voksne og l4);ancylostoma tubaeforme (mature adult, umodne voksne og l4). bændelorm (cestodes)dipylidium caninum (gamle voksne og umodne voksne);taenia taeniaeformis (voksen);echinococcus multilocularis (voksen). lungwormsaelurostrongylus abstrusus (voksen). dogsfor hunde, der lider af, eller er i risiko fra, blandet parasitære infektioner forårsaget af rundorm og bændelorm af følgende arter:rundorme (nematoder):toxocara canis (mature adult, umodne voksne, l4 og l3);toxascaris leonina (mature adult, umodne voksne og l4);ancylostoma caninum (gamle voksne og umodne voksne);uncinaria stenocephala (gamle voksne og umodne voksne);trichuris vulpis (mature adult, umodne voksne og l4);bændelorm (cestodes):dipylidium caninum;taenia spp. ;echinococcus multilocularis (gamle voksne og umodne);echinococcus granulosus (gamle voksne og umodne).